The steps required for successful market access.
Jon Williams, President of Evidera, is well-placed to offer his views on the issues impacting access to therapies.
Pharma 2022: big pharma to maintain its position, ready to pounce on any newcomer that shows promise.
After a few false dawns over the years, has virtual reality’s time come?
Prevention and self-management increasingly important in healthcare systems of the future.
How developments in gene editing and screening technology are advancing regenerative medicine.
What pharma brand management must entail to ensure pharma retains its position and maintains sales.